Budget impact analysis of comprehensive genomic profiling for untreated advanced or recurrent solid cancers in Japan.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical economics"
DOI: 10.1080/13696998.2023.2202599
Abstract: AIMS In Japan, the use of comprehensive genomic profiling (CGP) is only available for cancer patients who have no standard of care (SoC), or those who have completed SoC. This may lead to missed treatment… read more here.
Keywords: testing soc; impact; advanced recurrent; cgp testing ... See more keywords